Bristol Myers' Cobenfy, the first new schizophrenia treatment in decades, shows early sales momentum and strong pipeline ...

Enanta Pharmaceuticals ( ($ENTA) ) has shared an announcement. On August 20, 2025, Enanta Pharmaceuticals announced it filed a patent infringement ...

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look ...

AbbVie and Genmab’s epcoritamab has shown promise as part of a combination treatment for relapsed or refractory follicular ...

AbbVie’s ABBV stock has risen 11.5% in the past month, mainly due to its beat-and-raise performance in the second quarter.

In vivo CAR T-cell therapies promise to revolutionize cancer treatment, enhancing access and reducing costs while addressing ...

Resmed has announced the election of Nicole Mowad-Nassar to its board of directors, effective August 15. The company also announced that board member Rich Sulpizio is thanked for two decades of ...

A large trial in a primary care setting found daily emollient use to be safe, feasible, and effective in reducing atopic ...

Hilton, Delta Airlines, American Express, Capital One, Sephora and more companies feature on PEOPLE's annual list of 100 ...

On May 12, Trump signed an executive order stating that U.S. consumers are being overcharged for prescription drugs and that ...

Pfizer (PFE) stock in focus as Enanta Pharmaceuticals (ENTA) sues the pharma giant in the EU, claiming its COVID pill ...